NCT01582217View on ClinicalTrials.gov

Patients Undergoing Percutaneous Coronary Intervention (PCI) Through Optimal Platelet Inhibition

CompletedOBSERVATIONAL
Enrollment

318

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Percutaneous Coronary InterventionDual Antiplatelet TherapyAspirinClopidogrel
Trial Locations (1)

10029

Mount Sinai Medical Center, New York

Sponsors

Collaborators (1)

Daiichi Sankyo
All Listed Sponsors
collaborator

Daiichi Sankyo

INDUSTRY

collaborator

Accumetrics, Inc.

INDUSTRY

lead

Icahn School of Medicine at Mount Sinai

OTHER